- Lobbying
- purdue pharma
Lobbying Arrangements Results for 'Purdue Pharma'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Monitored congressional activity related to Medicare, Medicaid, PDUFA, public health, mental health and substance use disorder treatment. Monitored congressional activity related to bankruptcy reform. |
Purdue Pharma, LP
|
in-house lobbying | |||
Details intellectual property legislation |
PURDUE PHARMA L.P.
|
Constantine Cannon, LLP | |||
Details U.S. and Canadian regulatory policies regarding prescription drug abuse |
Purdue Pharma
|
MCKENNA, LONG & ALDRIDGE | |||
Details Monitoring legislative and regulatory activities impacting the pharmaceutical industry. |
Purdue Pharma L.P.
|
Hannegan Landau Poersch & Rosenbaum Advocacy, LLC | |||
Details U.S. and Canadian regulatory policies regarding prescription drug abuse |
Purdue Pharma
|
Dentons US LLP | |||
Details Monitoring legislative and regulatory activities impacting the pharmaceutical industry Monitoring legislative related to changes affecting corporate bankruptcy including issues related to third par... |
Purdue Pharma L.P.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Judiciary Committee hearing on Western District of Virginia plea agreement |
Purdue Pharma L.P.
Pharmaceutical company |
King & Spalding LLP | |||
Details Settlement agreement. |
The Official Committee of Unsecured Creditors of Purdue Pharma L.P., et al
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Patient access to abuse deterrent pain relief drugs |
Purdue Pharma L.P.
|
SIDLEY AUSTIN LLP | |||
Details S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672... |
America's Specialty Medicine Companies
|
Constantine Cannon, LLP | |||
Details Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceu... |
PURDUE PHARMA, LLP
|
CAPITOL HILL CONSULTING GROUP |